A Randomized Trial of the Optimum Duration of Acoustic Pulse Thrombolysis Procedure in Acute Intermediate-Risk Pulmonary Embolism: The OPTALYSE PE Trial.

2.50
Hdl Handle:
http://hdl.handle.net/11287/620806
Title:
A Randomized Trial of the Optimum Duration of Acoustic Pulse Thrombolysis Procedure in Acute Intermediate-Risk Pulmonary Embolism: The OPTALYSE PE Trial.
Authors:
Tapson, V. F. [et al]; Sharp, Andrew
Abstract:
The aim of this study was to determine the lowest optimal tissue plasminogen activator (tPA) dose and delivery duration using ultrasound-facilitated catheter-directed thrombolysis (USCDT) for the treatment of acute intermediate-risk (submassive) pulmonary embolism.
Citation:
A Randomized Trial of the Optimum Duration of Acoustic Pulse Thrombolysis Procedure in Acute Intermediate-Risk Pulmonary Embolism: The OPTALYSE PE Trial. 2018, 11 (14):1401-1410 JACC Cardiovasc Interv
Publisher:
Elsevier
Journal:
JACC. Cardiovascular interventions
Issue Date:
23-Jul-2018
URI:
http://hdl.handle.net/11287/620806
DOI:
10.1016/j.jcin.2018.04.008
PubMed ID:
30025734
Additional Links:
https://linkinghub.elsevier.com/retrieve/pii/S1936-8798(18)30925-7
Note:
This article is freely available via Open Access. Click on the Additional Link above to access the full-text via the publisher's site.
Type:
Journal Article
Language:
en
ISSN:
1876-7605
Appears in Collections:
Cardiology; 2018 RD&E publications

Full metadata record

DC FieldValue Language
dc.contributor.authorTapson, V. F. [et al]en
dc.contributor.authorSharp, Andrewen
dc.date.accessioned2018-07-30T11:19:50Z-
dc.date.available2018-07-30T11:19:50Z-
dc.date.issued2018-07-23-
dc.identifier.citationA Randomized Trial of the Optimum Duration of Acoustic Pulse Thrombolysis Procedure in Acute Intermediate-Risk Pulmonary Embolism: The OPTALYSE PE Trial. 2018, 11 (14):1401-1410 JACC Cardiovasc Interven
dc.identifier.issn1876-7605-
dc.identifier.pmid30025734-
dc.identifier.doi10.1016/j.jcin.2018.04.008-
dc.identifier.urihttp://hdl.handle.net/11287/620806-
dc.description.abstractThe aim of this study was to determine the lowest optimal tissue plasminogen activator (tPA) dose and delivery duration using ultrasound-facilitated catheter-directed thrombolysis (USCDT) for the treatment of acute intermediate-risk (submassive) pulmonary embolism.en
dc.language.isoenen
dc.publisherElsevieren
dc.relation.urlhttps://linkinghub.elsevier.com/retrieve/pii/S1936-8798(18)30925-7en
dc.rightsArchived with thanks to JACC. Cardiovascular interventionsen
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subjectWessex Classification Subject Headings::Cardiologyen
dc.titleA Randomized Trial of the Optimum Duration of Acoustic Pulse Thrombolysis Procedure in Acute Intermediate-Risk Pulmonary Embolism: The OPTALYSE PE Trial.en
dc.typeJournal Articleen
dc.identifier.journalJACC. Cardiovascular interventionsen
dc.description.noteThis article is freely available via Open Access. Click on the Additional Link above to access the full-text via the publisher's site.en
dc.type.versionPublisheden

Related articles on PubMed

This item is licensed under a Creative Commons License
Creative Commons
All Items in RD&E Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.